Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonkovsky

Showing results (341-350 of 351) with videos related to

Pageof 36
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 11, 2019
International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyriasBrenden Chen, Sharon Whatley, Michael Badminton, et al.
Hepatology (Baltimore, Md.)|January 23, 2018
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effortRachel J Church, Gerd A Kullak-Ublick, Jiri Aubrecht, et al.
Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.
Journal of Autoimmunity|August 10, 2020
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug developmentArie Regev, Mark I Avigan, Alexandre Kiazand, et al.
Toxicology Reports|March 7, 2020
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extractsHellen A Oketch-Rabah, Amy L Roe, Cynthia V Rider, et al.
Molecular Genetics and Metabolism|July 3, 2026
Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX)Karl E Anderson, Robert J Desnick, Herbert L Bonkovsky, et al.
The New England Journal of Medicine|July 2, 2015
Afamelanotide for Erythropoietic ProtoporphyriaJanneke G Langendonk, Manisha Balwani, Karl E Anderson, et al.
The Lancet. Haematology|May 2, 2026
Guidelines for the management of acute porphyria: recommendations from the International Porphyria NetworkYonatan Edel, Penelope E Stein, Hassan Kawtharany, et al.
Hepatology (Baltimore, Md.)|September 13, 2019
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent AttacksLaurent Gouya, Paolo Ventura, Manisha Balwani, et al.
The New England Journal of Medicine|June 11, 2020
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent PorphyriaManisha Balwani, Eliane Sardh, Paolo Ventura, et al.
Pageof 36

Showing results (341-350 of 351) with videos related to

Sort By:
Pageof 36
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 11, 2019
International Porphyria Molecular Diagnostic Collaborative: an evidence-based database of verified pathogenic and benign variants for the porphyriasBrenden Chen, Sharon Whatley, Michael Badminton, et al.
Hepatology (Baltimore, Md.)|January 23, 2018
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effortRachel J Church, Gerd A Kullak-Ublick, Jiri Aubrecht, et al.
Hepatology (Baltimore, Md.)|May 13, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trialTania Mara Welzel, Timothy R Morgan, Herbert L Bonkovsky, et al.
Journal of Autoimmunity|August 10, 2020
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug developmentArie Regev, Mark I Avigan, Alexandre Kiazand, et al.
Toxicology Reports|March 7, 2020
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extractsHellen A Oketch-Rabah, Amy L Roe, Cynthia V Rider, et al.
Molecular Genetics and Metabolism|July 3, 2026
Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX)Karl E Anderson, Robert J Desnick, Herbert L Bonkovsky, et al.
The New England Journal of Medicine|July 2, 2015
Afamelanotide for Erythropoietic ProtoporphyriaJanneke G Langendonk, Manisha Balwani, Karl E Anderson, et al.
The Lancet. Haematology|May 2, 2026
Guidelines for the management of acute porphyria: recommendations from the International Porphyria NetworkYonatan Edel, Penelope E Stein, Hassan Kawtharany, et al.
Hepatology (Baltimore, Md.)|September 13, 2019
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent AttacksLaurent Gouya, Paolo Ventura, Manisha Balwani, et al.
The New England Journal of Medicine|June 11, 2020
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent PorphyriaManisha Balwani, Eliane Sardh, Paolo Ventura, et al.
Pageof 36